Launched on 10 September 2026, the ALZEVIT study will genotype 50,000 volunteers aged 45 and over to build France’s first national APOE registry. Amoneta’s CE-IVDR marked APO-Easy® Genotyping Kit is the genotyping solution behind Phase A.
Amoneta announces the CE-marking under the EU-IVDR of its APO-Easy® Genotyping Kit.
Amoneta Diagnostics' innovative diagnostic tools are now available on the MedicalExpo platform
Huningue, France, December 12, 2023Together, Amoneta Diagnostics and the AD Data Initiative announce a collaboration to make data...
Amoneta Diagnostics announces that it has become a member of the Pépinière d'entreprises innovantes pH8, the region's premier business incubator focusing on healthcare and new technologies.